Status: Not yet recruiting
A Multicenter Open-label Phase II Study of Cemiplimab Plus Chemotherapy, Selected on the Basis of Baseline Cytidine Deaminase Activity, in Advanced Squamous Non-small Cell Lung Cancer
This is a multicenter phase II study enrolling treatment- naïve patients with metastatic or recurrent squamous carcinoma of the lung
Participants needed: 108
Trial details
Phase: Phase 2Age: 18+Biological sex: AllType: InterventionalSponsor: Gruppo Oncologico Italiano di Ricerca ClinicaUpdated: Feb 18, 2026Locations: 15
Eligibility criteria
Capable of giving signed informed consent which includes compliance with the req... [+25]
Patients with a sensitizing mutation in the epidermal growth factor receptor (EG... [+49]